Vineti

aid: vineti
name: Vineti
description: 'Vineti was an enterprise software company for cell and gene therapy supply chain management, headquartered in
  San Francisco and founded in 2016. Its Personalized Therapy Management (PTM) platform — sold as PTM Enterprise and PTM Essentials
  — orchestrated the patient-centric supply chain behind autologous and allogeneic cell therapies, gene therapies and personalized
  cancer vaccines: chain of identity, chain of custody, apheresis and manufacturing scheduling, clinical-site workflows, and
  regulatory reporting. PTM was delivered as a configurable aPaaS on AWS, with HIPAA compliance certified by Avertium and
  GAMP-aligned validation. Vineti was named a World Economic Forum Technology Pioneer and raised a $35M Series C in 2020.
  The PTM software was acquired by Johnson & Johnson in 2023 to continue supporting its commercial therapy rollouts and clinical
  trials, and Vineti ceased to operate as an independent company: vineti.com no longer resolves and the domain now sits on
  Johnson & Johnson name servers. This profile is retained as a historical record — there is no live API surface to catalog.'
url: https://raw.githubusercontent.com/api-evangelist/vineti/refs/heads/main/apis.yml
x-harvest-source-url: https://forgeglobal.com/vineti_stock/
deliveryModel:
  model: unknown
  open_source: false
  commercial: false
  callable_host: false
  label: Delivery model not determined — needs a product licence on record
  confidence: low
  source:
  - none
  generated: '2026-08-28'
  method: derived
image: https://web.archive.org/web/2023id_/https://vineti.com/wp-content/uploads/2021/05/cropped-Vineti_Favicon-1-192x192.png
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
x-status: defunct
specificationVersion: '0.23'
created: '2026-08-05'
modified: '2026-08-05'
tags:
- Company
- Cell and Gene Therapy
- Life Sciences
- Supply Chain
- Healthcare
- Clinical Trials
- Pharmaceuticals
- Enterprise Software
- Defunct
tags_raw:
- Company
- Cell and Gene Therapy
- Life Sciences
- Supply Chain
- Healthcare
- Clinical Trials
- Pharmaceutical
- Enterprise Software
- Defunct
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: ParentCompany
  url: https://apis.io/providers/johnson-and-johnson/
  name: Johnson & Johnson
  x-relationship: acquired
  x-evidence: 'The PTM software was acquired by Johnson & Johnson in 2023 to continue supporting its commercial therapy rollouts
    and clinical trials, and Vineti ceased to operate as an independent company: vineti.'
- type: GitHubOrganization
  url: https://github.com/vinetiworks
x-enrichment:
  date: '2026-08-05'
  status: minimal
  artifacts_added: 0
  pass: local-v1
x-coverage:
  state: none
  reason: defunct
  detail: Vineti's PTM software was acquired by Johnson & Johnson in 2023 and the company no longer operates — vineti.com
    has no A record at all (its name servers are now ns01-04.jnjdns.com), every subdomain probed (api., app., docs., developer.,
    portal., status.) is NXDOMAIN, and the last Wayback capture of the site is 2023-04-07, so there is no host left to run
    contract discovery against.
  evidence:
  - url: https://vineti.com/
    status: 0
  - url: https://api.vineti.com/openapi.json
    status: 0
  - url: https://vineti.com/.well-known/agent-card.json
    status: 0
  - url: https://web.archive.org/web/20230407042038/https://vineti.com/
    status: 200
  - url: https://github.com/vinetiworks
    status: 200
  checked: '2026-08-05'